Terbinafine: Mode of action and properties of the squalene epoxidase inhibition

British Journal of Dermatology

Volumn 126, Issue , 1992, Pages 2-7

  RYDER, N S ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

SQUALENE MONOOXYGENASE; TERBINAFINE;

ANTIFUNGAL ACTIVITY; CANDIDA; CONFERENCE PAPER; CONTROLLED STUDY; PHARMACODYNAMICS; PRIORITY JOURNAL; TRICHOPHYTON RUBRUM;

ANTIFUNGAL AGENTS; ERGOSTEROL; FUNGI; NAPHTHALENES; OXYGENASES;

EID: 0026567044     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1992.tb00001.x     Document Type: Article

References (33)

1. Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase
2. In vitro activity of naftifine, a new antifungal agent
3. Synthesis and structure‐activity correlations within allylamine antimycotics
4. Allylamine antifungal drugs
5. Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicans
6. Specific inhibition of fungal sterol biosynthesis by SF 86‐327, a new allylamine antimycotic agent
7. Inhibition of squalene epoxidase by allyamine antimycotic compounds: a comparative study of the fungal and mammalian enzymes
8. Biochemical mode of action of the allylamine antimycotic agents naftifine and terbinafine
9. Mechanism of action of the allylamine antimycotics
10. Mechanism of action and biochemical selectivity of allylamine antimycotic agents
11. Mode of action of allylamines
12. The mechanism of action of terbinafine
13. Effect of allylamine antimycotic agents on fungal sterol biosynthesis measured by sterol side‐chain mathylation
14. Biochemical mode of action and enantiomeric selectivity of SDZ 89–485, a new triazole antimycotic
15. Inhibitory effect of antifungal agents on germ tube formation in Candida albicans
16. The molecular basis for the antifungal activities of N‐substituted azole derivatives. Focus on R 51 211
17. Antifungal activity of the allylamine derivative terbinafine in vitro
18. Experimental antimycotic activity of naftifine and terbinafine
19. Mechanism of the fungicidal action of SF 86–327, a new allylamine antimycotic agent
20. SF 86–327: effects on the ultrastructure of Trichophyton mentagrophytes in vitro
21. SF 86–327: effects on the ultrastructure of Candida albicans in vitro
22. Morphological changes induced by naftifine, a new antifungal agent, in Trichophyton mentagrophytes
23. Location of squalene accumulation and physiological effects of ergosterol depletion in naftifine‐grown yeast
24. Squalene epoxidase: enzymology and inhibition
25. Properties of a particulate squalene epoxidase from Candida albicans
26. Squalene epoxidase as the target of antifungal allylamines
27. Squalene epoxidase as a target for the allylamines
28. The interaction of representative members from two classes of antimycotics—the azoles and the allylamines—with cytochrome P‐450 in steroidogenic tissues and liver
29. Potential of allylamines to inhibit cytochrome P‐450
30. Interaction of terbinafine with cytochrome P‐450 in vitro and in vivo in man
31. Comparative effects of two antimycotic agents, ketoconazole and terbinafine, on the metabolism of tolbutamide, ethinyloestradiol, cyclosporine and ethoxycoumarin by human liver microsomes in vitro
32. Resistance to inhibitors of sterol biosynthesis in field isolates or laboratory strains of the eyespot pathogen Pseudocercosporella herpotrichoides
33. The lipid compositions of two isolates of Cladosporium cucumerinum do not explain their differences in sensitivity to fungicides which inhibit sterol biosynthesis